Overview

Opioid Effects on Swallowing and Esophageal Sphincter Pressure

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a dopamine receptor antagonist metoclopramide can counteract opioid induced effects on esophageal motility and lower esophageal sphincter. The aim of this study is also to evaluate if the opioid antagonist naloxone reduces the opioid induced pharyngeal and esophageal dysfunction.
Phase:
Phase 4
Details
Lead Sponsor:
Region Örebro County
Treatments:
Metoclopramide
Naloxone
Remifentanil